OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Influence of smoking on the efficacy of antimalarials in cutaneous lupus: A meta-analysis of the literature
François Chasset, Camille Françès, Stéphane Barète, et al.
Journal of the American Academy of Dermatology (2015) Vol. 72, Iss. 4, pp. 634-639
Closed Access | Times Cited: 103

Showing 1-25 of 103 citing articles:

Systemic lupus erythematosus: Diagnosis and clinical management
Andrea Fava, Michelle Petri
Journal of Autoimmunity (2018) Vol. 96, pp. 1-13
Open Access | Times Cited: 577

EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen, et al.
Annals of the Rheumatic Diseases (2023) Vol. 83, Iss. 1, pp. 15-29
Open Access | Times Cited: 368

The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
Caroline Gordon, Maame-Boatemaa Amissah-Arthur, Mary Gayed, et al.
Lara D. Veeken (2017) Vol. 57, Iss. 1, pp. e1-e45
Open Access | Times Cited: 306

Smoke and autoimmunity: The fire behind the disease
Carlo Perricone, Mathilde Versini, Dana Ben-Ami, et al.
Autoimmunity Reviews (2016) Vol. 15, Iss. 4, pp. 354-374
Closed Access | Times Cited: 217

Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge
Alina Dima, Ciprian Jurcuț, François Chasset, et al.
Therapeutic Advances in Musculoskeletal Disease (2022) Vol. 14
Open Access | Times Cited: 125

Systemic lupus erythematosus
Alberta Hoi, Talia Igel, Chi Chiu Mok, et al.
The Lancet (2024) Vol. 403, Iss. 10441, pp. 2326-2338
Closed Access | Times Cited: 64

Drugs for discoid lupus erythematosus
Sue Jessop, D A Whitelaw, Matthew J. Grainge, et al.
Cochrane library (2017) Vol. 2017, Iss. 5
Open Access | Times Cited: 131

Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors
Laurent Arnaud, Maria G. Tektonidou
Lara D. Veeken (2020) Vol. 59, Iss. Supplement_5, pp. v29-v38
Open Access | Times Cited: 128

Cutaneous Lupus Erythematosus: An Update on Pathogenesis, Diagnosis and Treatment
Emily Hejazi, Victoria P. Werth
American Journal of Clinical Dermatology (2016) Vol. 17, Iss. 2, pp. 135-146
Closed Access | Times Cited: 100

Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus
Ioannis Parodis, Christopher Sjöwall, Andreas Jönsen, et al.
Autoimmunity Reviews (2017) Vol. 16, Iss. 4, pp. 343-351
Closed Access | Times Cited: 96

Efficacy and comparison of antimalarials in cutaneous lupus erythematosus subtypes: a systematic review and meta-analysis
François Chasset, Jean‐David Bouaziz, N. Costedoat‐Chalumeau, et al.
British Journal of Dermatology (2017) Vol. 177, Iss. 1, pp. 188-196
Closed Access | Times Cited: 87

The Main Challenges in Systemic Lupus Erythematosus: Where Do We Stand?
Matteo Piga, Laurent Arnaud
Journal of Clinical Medicine (2021) Vol. 10, Iss. 2, pp. 243-243
Open Access | Times Cited: 76

The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis
José María Pego‐Reigosa, Lindsay Nicholson, Nick Pooley, et al.
Lara D. Veeken (2020) Vol. 60, Iss. 1, pp. 60-72
Open Access | Times Cited: 74

Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus
Qianjin Lu, Hai Long, Steven Chow, et al.
Journal of Autoimmunity (2021) Vol. 123, pp. 102707-102707
Open Access | Times Cited: 59

10 most important contemporary challenges in the management of SLE
Renaud Felten, Flora Sagez, Pierre‐Edouard Gavand, et al.
Lupus Science & Medicine (2019) Vol. 6, Iss. 1, pp. e000303-e000303
Open Access | Times Cited: 73

Efficacy and tolerance profile of thalidomide in cutaneous lupus erythematosus: A systematic review and meta-analysis
François Chasset, T. Tounsi, E. Cesbron, et al.
Journal of the American Academy of Dermatology (2017) Vol. 78, Iss. 2, pp. 342-350.e4
Closed Access | Times Cited: 67

Anifrolumab for treatment of refractory cutaneous lupus erythematosus
Franklin R. Blum, Ashwath J. Sampath, Galen Foulke
Clinical and Experimental Dermatology (2022) Vol. 47, Iss. 11, pp. 1998-2001
Closed Access | Times Cited: 32

Updated recommendations on the use of hydroxychloroquine in dermatologic practice
Anthony P. Fernandez
Journal of the American Academy of Dermatology (2017) Vol. 76, Iss. 6, pp. 1176-1182
Open Access | Times Cited: 50

Impact of tobacco smoking upon disease risk, activity and therapeutic response in systemic lupus erythematosus: A systematic review and meta-analysis
Dorian Parisis, Charlie Bernier, François Chasset, et al.
Autoimmunity Reviews (2019) Vol. 18, Iss. 11, pp. 102393-102393
Open Access | Times Cited: 49

Current Insights in Cutaneous Lupus Erythematosus Immunopathogenesis
Colton J. Garelli, Maggi Ahmed Refat, Padma P. Nanaware, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 41

Smoking and the risk of systemic lupus erythematosus: an updated systematic review and cumulative meta-analysis
Fan Jiang, Suyun Li, Chongqi Jia
Clinical Rheumatology (2015) Vol. 34, Iss. 11, pp. 1885-1892
Closed Access | Times Cited: 45

Smoking and Its Association With Morbidity in Systemic Lupus Erythematosus Evaluated by the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index: Preliminary Data and Systematic Review
Ricardo Azêdo de Luca Montes, Luiz Otávio Cardoso Mocarzel, Pedro Gemal Lanzieri, et al.
Arthritis & Rheumatology (2015) Vol. 68, Iss. 2, pp. 441-448
Open Access | Times Cited: 44

Increased Myeloid Dendritic Cells and TNF-α Expression Predicts Poor Response to Hydroxychloroquine in Cutaneous Lupus Erythematosus
Majid Zeidi, Hee Joo Kim, Victoria P. Werth
Journal of Investigative Dermatology (2018) Vol. 139, Iss. 2, pp. 324-332
Open Access | Times Cited: 43

Cutaneous lupus erythematosus: A review of the literature
Stephanie Blake, Benjamin S. Daniel
International Journal of Women’s Dermatology (2019) Vol. 5, Iss. 5, pp. 320-329
Open Access | Times Cited: 40

Fatigue in Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Comparison of Mechanisms, Measures and Management
Mrinalini Dey, Ioannis Parodis, Elena Nikiphorou
Journal of Clinical Medicine (2021) Vol. 10, Iss. 16, pp. 3566-3566
Open Access | Times Cited: 30

Page 1 - Next Page

Scroll to top